Sanjay Nayak, Chief Strategy Officer at OCULAR THERAPEUTIX, INC (OCUL), sold 10,348 shares at $9.04 ($94K) on 2026-02-12, disclosed to the SEC on 2026-02-17.
Open-market sale of $94k OCUL by Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| OCUL | SELL | 2026-02-25 | $15K | — | Filing → |
| OCUL | SELL | 2025-11-26 | $23K | — | Filing → |
| OCUL | SELL | 2025-08-27 | $23K | — | Filing → |